Upadacitinib improves PsA in phase III trial
Crossref DOI link: https://doi.org/10.1038/s41584-021-00617-y
Published Online: 2021-04-20
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onuora, Sarah
Text and Data Mining valid from 2021-04-20
Version of Record valid from 2021-04-20
Article History
First Online: 20 April 2021